Pinnacle Medicines

Private

Doylestown, PennsylvaniaHealthcare & Life Scienceshttps://www.pinnaclemedicines.com/language/en/index.php

Last Round

Series B

Mar 26, 2026

Total Funding Raised

$179M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Pinnacle Medicines is a biotechnology company that develops oral peptide therapeutics designed to deliver biologic-level efficacy with the convenience of oral dosing for immunology and cardiometabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

oral peptide therapeuticsAI drug discoveryAI biotechdrug discovery platformoral biologicsstructure-based drug designSBDDcomputational drug discoverypeptide therapeuticsde novo peptide designphysics-based simulationsimmunologycardiometabolic diseasespreclinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pinnacle Medicines Comps

Public and private peers based on sector, stage, and business model.

Pinnacle Medicines comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pinnacle Medicines Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Mar 26, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Sandeep Somani

Co-Founder, CTO

Founding Team

Pinnacle Medicines Investors

Notable investors and investment history

Pinnacle Medicines investors
Investor	Rounds
RA Capital Management	Series B
OrbiMed	Series B, Series A
Logos Capital	Series B
Foresite Capital	Series B
Lilly Asia Ventures	Series B
Hankang Capital	Series B
Qiming Venture Partners	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 22, 2026
Open roles increased to 4, 4x the trailing average.
Jun 2, 2026
Grew 24% QoQ from 17 to 21 employees.

View all signals

Pinnacle Medicines Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Pinnacle Medicines Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pinnacle Medicines's valuation, stock price, and market status.

Firmographic Details

HeadquartersDoylestown, Pennsylvania

Employee Range21

Year Founded2024

Last FundingMar 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.